Immunotherapy for metastatic cancer. Establishing a 'proof of principle'.
Hellman
S
S
D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy; D008545:Melanoma / Q000556:secondary / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2